About Boehringer Ingelheim
Boehringer Ingelheim is dedicated to the research and development of medical products to improve, sustain and care for life.
We have a reputation for providing effective products for the treatment of chronic obstructive pulmonary disease (COPD), heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, HIV/AIDS, Parkinson's disease, arthritis and pain relief in cancer.
Our products are supported by a wide range of services, designed to help the medical profession deliver the best possible healthcare to patients.
This underlines our commitment to improving health and quality of life in the UK.
Boehringer Ingelheim is a family owned company whose distinctly independent structure means that we are not constrained by the short-term needs of individual shareholders and can focus on the future with long-term strategies of vision and leadership.
Despite our aim to change and adapt for the future, we will never change the belief that our employees are our most valuable asset.
We are proud to be ranked among the top 100 Best Companies once again in 2011.
The spirit and teamwork of our global family will remain the key to our continuing success.
It is possible to sum up what the Boehringer Ingelheim group of companies believes in and strives for in a single phrase:
"Value through Innovation"
It recognises that in a competitive and fast changing world, the values of products, services and companies are constantly changing. In order for things to have real value to the customer, they have to be superior to any other offering - and therefore better than they were before. Real customer value can only be created by the Boehringer Ingelheim group of companies constantly finding ways of doing new things well, or doing the same things better. Thus the only way for the company to create Value is through Innovation.
View an Interview with Director of Sales Amanda Paxon
For more information please contact your Boehringer Ingelheim Account Manager